Specialty Pharmacy

Rebecca Shanahan to discuss the optimal role of specialty pharmacies in improving health outcomes at this premier industry event

Study indicates inflammatory bowel disease treatment needs careful consideration before prescribing.

Study finds significant racial and geographic disparity in prevalence of monoclonal gammopathy of undetermined significance.

Patients with Crohn's Disease receiving infliximab or adalimumab had similar remission rates and few side effects, the results of an Italian study suggest.

An increase in the number of available anti-cancer drugs will also help lead to more people surviving the disease than ever before.

Integrated clinical and specialty pharmacy practice model includes an interdisciplinary team of physicians, nurses, and pharmacists.

Armada introduces mobile app for record crowd expected at upcoming Summit & Expo in Las Vegas.

More patients with Lynch syndrome will be eligible for genetic testing with availability of a new, more sensitive assay from Myriad Genetics and support for wider use of the test through guidelines issued by the National Comprehensive Cancer Network.

Researchers safely infuse engineered immune cells in groundbreaking gene therapy study.

Suzanne Tschida, PharmD, BCPS, vice president of specialty benefit and outcomes strategy at OptumRx, talks about how specialty medications are better suited for distribution through a specialty pharmacy over a retail location.

The Midwestern grocery chain has reached agreement to purchase specialty pharmacy solutions provider Amber Pharmacy.

Recent Behçet's disease research has focused on the most frequently seen disease symptoms, but treatment for rarer disease manifestations may suffer as a result.

New program aims to help providers identify compounding facilities that meet more rigorous standards around quality and patient safety.

Using a very high sensitivity assay analyzing changes in levels of MPO and troponin I before, and 3 months after starting a chemotherapy regimen, investigators were able to predict 46.5% of cases of chemotherapy-associated cardiotoxicity before they occurred.

Deaths from chronic hepatitis C virus infection in the United States are grossly underreported, the results of a new study indicate.

Expert on long-term patient outcomes says pharmacists have an ideal opportunity to help patients live healthier lives, lower health care costs.

Double-digit annual spending increases for specialty drugs are forecast through 2015, reports America's Health Insurance Plans.

Avella Collaborates with NIH in Renal Transplant Patient Adherence Study

Of the 3 to 4 million Americans with chronic HCV infection, only 13% to 18% have received treatment. Understanding the current guidelines in HCV treatment and understanding the current role of direct-acting antiviral agents is an important priority for pharmacists.

Participants receiving tocilizumab therapy for rheumatoid arthritis were more likely to have acquired factor XIII deficiency than those receiving other therapies.

A child born infected with HIV in California began treatment hours after birth, and is clear of virus 9 months later.

Gary Rice, RPh, MS, MBA, vice president of clinical services at Diplomat Specialty Pharmacy, talks about Diplomat's adherence program.

Cutaneous reactions occurred in most participants in a Netherlands-based multiple sclerosis therapy study, lowering dermatologic-specific quality-of-life scores.

Noting advances in hepatitis C treatment regimens, Walgreens expands access to its hepatitis C–focused patient care program.

A combination of daclatasvir and asunaprevir for type-1b hepatitis C virus infection has received breakthrough therapy designation by the FDA, meaning a faster path to approval.

Isotretinoin, a treatment for severe acne, has been linked to inflammatory bowel disease (IBD) in some case reports and 1 study. To investigate whether isotretinoin can induce IBD, French researchers conducted a 2-year nationwide registry study.

A proposed bill allowing biosimilar substitution in Georgia mirrors the state's generic drug substitution regulations.

Poorly controlled type 2 diabetes mellitus in patients with multiple myeloma (MM) may increase the risk of adverse cardiovascular outcomes, kidney damage, and peripheral neuropathy. Considering the effect of medications to treat MM on blood glucose control may be an important part of choosing a treatment regimen for some patients.